The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a ...

India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia. These new eye drops, known as PresVuand manufactured by Mumbai-based Entod ...

Entod Pharmaceuticals is facing action from the Gujarat state drug regulatory authority for allegedly violating the Drugs and Magic Remedies Act by promoting its eye drops for presbyopia through a ...

The risk of systemic side effects is greater in infants than in adults due to increased percutaneous drug absorption and lower blood volume. The closed eyes technique of eyedrop administration is ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The DCGI has halted the authorization given to Mumbai-based Entod Pharmaceuticals to produce and market its novel eye ... drug maker also submitted its response. In response to the claim "first ...

NEW DELHI: India’s drug regulator has suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop could help people reduce ...

At the end of each month, unused surgery-center supplies of the drug used that month were collected ... Aseptic technique was used when eye drops were administered to patients.

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

The Drug Controller General of India has suspended the licence for PresVu eye drops from Entod Pharmaceuticals over unauthorised promotion and safety concerns. Entod plans to challenge this ...

The situation escalated when the Drug Controller General of India suspended the marketing and distribution licence of PresVu eye drops. The suspension was issued due to unauthorised promotional ...

Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding the PresVu eye drops, a press release from the company ...